Boothbay Fund Management, LLC Roivant Sciences Ltd. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$9.08 - $11.62 $888,033 - $1.14 Million	-97,801 Reduced 70.93%	40,084 $451,000
Q1 2025 May 15, 2025	BUY	$10.09 - $12.08 $1.11 Million - $1.33 Million	110,271 Added 399.33%	137,885 $1.39 Million
Q4 2024 Feb 14, 2025	SELL	$11.16 - $12.71 $1,149 - $1,309	-103 Reduced 0.37%	27,614 $326,000
Q1 2024 May 15, 2024	SELL	$9.87 - $11.8 $86,806 - $103,781	-8,795 Reduced 24.09%	27,717 $292,000
Q4 2023 Feb 14, 2024	BUY	$8.38 - $11.58 $305,970 - $422,808	36,512 New	36,512 $410,000

Q2 2023 Aug 14, 2023	SELL	$7.09 - $10.08 $694,422 - $987,275	-97,944 Reduced 68.44%	45,158 $455,000
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $990,265 - $1.43 Million	143,102 New	143,102 $1.06 Million

376

443M

6.03M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $14.3B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.